Cyclopharm Limited Share Price
Stocks
CYC
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
10:40:10 28/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.3700 AUD | 0.00% |
|
-6.33% | -62.24% |
| Market Cap | 4.65Cr 3.28Cr 2.94Cr 2.72Cr 2.46Cr 4.6Cr 311.92Cr 32Cr 13Cr 163.22Cr 12Cr 12Cr 518.16Cr | P/E 2026 * |
-2.63x | P/E 2027 * | -4.13x |
|---|---|---|---|---|---|
| Enterprise Value | 4.65Cr 3.28Cr 2.94Cr 2.72Cr 2.46Cr 4.6Cr 311.92Cr 32Cr 13Cr 163.22Cr 12Cr 12Cr 518.16Cr | EV / Sales 2026 * |
1.25x | EV / Sales 2027 * | 0.99x |
| Free-Float |
51.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cyclopharm Limited
| 1 week | -6.33% | ||
| Current month | -18.68% | ||
| 1 month | -17.78% | ||
| 3 months | -31.48% | ||
| 6 months | -48.61% | ||
| Current year | -62.24% |
| 1 week | 0.33 |  | 0.38 |
| 1 month | 0.33 | | 0.52 |
| Current year | 0.33 | | 1.29 |
| 1 year | 0.33 | | 1.29 |
| 3 years | 0.33 | | 2.5 |
| 5 years | 0.33 | | 3.15 |
| 10 years | 0.33 | | 3.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 21/10/2009 |
Jason Smith
DFI | Director of Finance/CFO | - | 26/02/2024 |
Mathew Farag
COO | Chief Operating Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
James McBrayer
BRD | Director/Board Member | 60 | 03/06/2008 |
Dianne Angus
BRD | Director/Board Member | 65 | 10/08/2021 |
Gregory King
BRD | Director/Board Member | - | 27/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/03/26 | Buy | Director | 21,052 | 0.0175% | ||
| 12/03/26 | Buy | Director | 5,263 | 0.0044% | ||
| 12/03/26 | Buy | Director | 21,052 | 0.0175% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.33% | -41.27% | -81.77% | 3.27Cr | |
| +1.74% | +1.79% | +26.69% | +62.74% | 26TCr | |
| +0.95% | +0.21% | +8.05% | +26.61% | 16TCr | |
| -0.07% | +4.15% | -18.24% | +72.50% | 15TCr | |
| -4.18% | -3.62% | -57.51% | -14.29% | 6.53TCr | |
| +0.43% | +3.20% | +10.99% | +46.29% | 5.23TCr | |
| +1.72% | +2.11% | -12.83% | -6.95% | 5.19TCr | |
| +1.07% | -1.31% | +8.58% | +66.25% | 5.08TCr | |
| +2.01% | +1.97% | +24.27% | +79.15% | 5TCr | |
| +1.73% | +4.13% | +37.70% | +101.26% | 4.6TCr | |
| Average | +0.53% | +0.93% | -1.36% | +35.18% | 8.9TCr | |
| Weighted average by Cap. | +0.74% | +1.68% | +5.47% | +50.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.72Cr 2.62Cr 2.35Cr 2.17Cr 1.97Cr 3.68Cr 249.42Cr 26Cr 10Cr 130.51Cr 9.83Cr 9.62Cr 414.34Cr | 4.72Cr 3.32Cr 2.98Cr 2.76Cr 2.5Cr 4.66Cr 316.46Cr 33Cr 13Cr 165.6Cr 12Cr 12Cr 525.72Cr |
| Net income | -1.74Cr -1.22Cr -1.1Cr -1.02Cr -92.02L -1.72Cr -116.66Cr -12Cr -4.84Cr -61Cr -4.6Cr -4.5Cr -193.8Cr | -1.24Cr -87.29L -78.32L -72.41L -65.58L -1.23Cr -83Cr -8.66Cr -3.45Cr -44Cr -3.28Cr -3.21Cr -138.11Cr |
| Net Debt | - | - |
Employees
104
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | A$0.3700 | 0.00% | 33,757 |
| 27/26/27 | A$0.3700 | -1.33% | 2,410 |
| 23/26/23 | A$0.3750 | +4.17% | 1,209 |
| 22/26/22 | A$0.3600 | -2.70% | 2,18,135 |
| 21/26/21 | A$0.3700 | -6.33% | 76,632 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2602USD
Average target price
0.7170USD
Spread / Average Target
+175.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CYC Stock
Select your edition
All financial news and data tailored to specific country editions
